The appetite suppression that semaglutide creates provides a window for establishing better eating habits, reducing ultra-processed food intake, and creating a sustainable caloric deficit
Studied in preclinical research on skin remodelling, wound-repair pathways, and gene-expression modulation
Many patients exhibit: Heat sensitivity Stress-triggered flushing Rapid redness changes Burning sensations This suggests dysregulation involving: Mast cells Nervous system signaling Blood vessel reactivity Stress, poor sleep, and cortisol dysregulation may amplify these pathways
I do hope so
Scott Butsch, MD, director of obesity medicine within the Cleveland Clinics Bariatric and Metabolic Institute, postulated that insurers still hesitate to see obesity as a disease and hence to cover treatments for it
T2D Coverage Through the Blue System Does Insurance Cover Ozempic